| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 04/21/2004 | EP1409453A1 Novel diamines having a casr modulating activity |
| 04/21/2004 | EP1409452A1 Sulfonamide derivatives |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1490310A Preparation of Duofeilite and its medicinal salts |
| 04/21/2004 | CN1146537C Dofetilide polymorphs |
| 04/20/2004 | US6723879 Process for preparing amino compounds by using salen-manganese complexes as the catalyst |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/15/2004 | WO2004031134A1 Process for making substituted aryl sulfonamides using an indium based catalyst system |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | CN1489459A Use of 2-amino-1 (4-hydroxy-2-methanesu/phonamidophenyl) ethanol for treating urinary incontinence |
| 04/14/2004 | CN1488620A 2-phenyl-camphol propionate derivativ and synthesizing method thereof |
| 04/13/2004 | US6720449 N-protecting an optically active 3-haloalanine derivative followed by cyclization for aziridine-2-carboxylic acid derivatives |
| 04/13/2004 | US6720357 Sulfonamide derivatives |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720317 Inhibitors of factor Xa |
| 04/08/2004 | WO2004029019A2 Compounds for the treatment of alzheimer’s disease |
| 04/08/2004 | WO2004006829A3 Method of separating r(-)- and s(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl-2-methoxybenzene-sulphonamide |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | US20040068126 Such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation, isomerization, cyclopropanation, Diels-Alder reaction, etc. |
| 04/08/2004 | US20040068012 Anticancer agents; protease enzyme inhibitor |
| 04/08/2004 | US20040067984 Psychological disorders; central nervous system disorders; cognition activators |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | CA2500109A1 Compounds for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404648A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action |
| 04/07/2004 | EP1305281B1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | CA2190992C Naphthalene derivatives |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004027788A1 Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells |
| 04/01/2004 | WO2004027388A2 Novel green and orange fluorescent labels and their uses |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063669 Alpha-phenyl-beta-ketosulfone |
| 04/01/2004 | CA2499185A1 Nonaqueous electrolyte, electrical double-layer capacitors, and nonaqueous electrolyte secondary cells |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1403235A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401806A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 03/31/2004 | EP1401805A1 Valproyltaurinamide derivatives as anticonvulsant and cns active agents |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 03/31/2004 | EP1003720B1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 03/31/2004 | EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/30/2004 | US6713654 Antimicrobial compounds |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713516 Sulphonamide derivatives |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2123885C Insecticidal phenylhydrazine derivatives |
| 03/25/2004 | WO2004024737A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms |
| 03/25/2004 | WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/25/2004 | WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | WO2004024089A2 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
| 03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | WO2003070694A3 Method for treating an imide organic solution bearing a sulphonyl group |
| 03/25/2004 | US20040059158 Method of friedel-crafts acylation of anilides |
| 03/25/2004 | US20040058988 Fatty acid synthase inhibitors |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 03/24/2004 | EP1399780A1 Method for purifying free-base p-phenylenediamine-type photographic color developers |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399418A1 NOVEL N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-$G(a)-SULFIN- AND $G(a)-SULFONAMINO ACID AMIDES |
| 03/24/2004 | EP1399414A2 Substituted tetracycline compounds for the treatment of malaria |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1240135B1 Method for preparing fluorosulfonyl imide monomer |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1142906C Intermediate for producing 2-trifluoromethoxy benzene sulfonamide |
| 03/23/2004 | US6710178 Preparation of 4-(4-flourophenyl)-6-alkyl-2-N-alkansulfonyl-N-alkylamino)pyrimidine-5-carboxylic acid ester |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |